The genomic loci for tumor suppressor p53 and ARF are the most frequently mutated in all types of human cancer. On the other hand, the proto-oncoprotein MDM2, a principle negative regulator of p53 in the cell, is frequently overexpressed in many types of human cancer, ARF, MDM2, and p53 constitute an important tumor suppression pathway (ARF-MDM2-p53 pathway) that safeguards cells from aberrant, uncontrolled growth. Recent studies have indicated that the ARF-MDM2-p53 pathway is not strictly linear but branches out to other targets and that the pathway crosstalks with other cellular pathways, presumably through the interaction with other cellular proteins. The targets of the branched-out interaction and the mechanisms of the crosstalk regulation, however, are largely elusive. We have recently found that MDM2 interacts with the ribosomal protein L11 through its zinc finger region. L11 forms in vivo complexes with ARF, MDM2, and p53. Enforced expression of L11 prevents MDM2-mediated p53 ubiquitination and degradation, restores MDM2-suppressed p53 transactivation activity and induces a p53-dependent G1 cell cycle arrest. More importantly, studies have shown that human cancer-associated mutations in the MDM2 gene preferentially target the zinc finger domain disrupting L11 binding. One of the cancer-derived MDM2 mutants we have examined, MDM2 (C305F),which has a Cys-to-Phe substitution in the central zinc finger motif, exhibited several distinct characteristics including the disruption of L11 binding. MDM2(C305F) retained the E3 ligase activity to ubiquitinate p53 but did not promote p53 degradation. It showed a stronger ability than the wild type MDM2 in suppressing p53's transactivation activity and cells expressing MDM2(C305F) escaped from L11 overexpression-induced growth inhibition. MDM2(C305F) represents a useful mutant to dissect the mechanism of L11-regulated MDM2 and p53 function. Based on our preliminary data, we hypothesize that the L11-MDM2-p53 connection constitutes a pathway that monitors the rate of protein synthesis and coordinates cell growth with cell cycle progression. To understand the function and regulation of the LI 1-MDM2-p53 pathway, we propose the following aims:
Aim 1. To investigate the mechanism and regulation of the MDM2-L11 interaction.
Aim 2. To investigate the in vivo function of the MDM2-L11 interaction using a MDM2 (C305F) knockin.
Aim 3. To investigate the mechanism of ARF in the regulation of L11, MDM2, and p53.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA100302-03
Application #
6994082
Study Section
Pathology B Study Section (PTHB)
Program Officer
Blair, Donald G
Project Start
2003-08-01
Project End
2008-07-31
Budget Start
2005-03-08
Budget End
2005-07-31
Support Year
3
Fiscal Year
2004
Total Cost
$324,850
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Liu, Yong; Leslie, Patrick L; Jin, Aiwen et al. (2018) p32 regulates ER stress and lipid homeostasis by down-regulating GCS1 expression. FASEB J 32:3892-3902
Leslie, Patrick L; Franklin, Derek A; Liu, Yong et al. (2018) p53 Regulates the Expression of LRP1 and Apoptosis through a Stress Intensity-Dependent MicroRNA Feedback Loop. Cell Rep 24:1484-1495
Liu, S; Tackmann, N R; Yang, J et al. (2017) Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis. Oncogene 36:1374-1383
Liu, Shijie; Kim, Tae-Hyung; Franklin, Derek A et al. (2017) Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure. Cell Rep 18:1005-1018
Tian, Hui; Tackmann, Nicole R; Jin, Aiwen et al. (2017) Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice. J Biol Chem 292:21614-21622
Di, Jiehui; Tang, Juanjuan; Qian, Heya et al. (2017) p53 upregulates PLC?-IP3-Ca2+ pathway and inhibits autophagy through its target gene Rap2B. Oncotarget 8:64657-64669
Tackmann, Nicole R; Zhang, Yanping (2017) Mouse modelling of the MDM2/MDMX-p53 signalling axis. J Mol Cell Biol 9:34-44
Franklin, Derek A; He, Yizhou; Leslie, Patrick L et al. (2016) p53 coordinates DNA repair with nucleotide synthesis by suppressing PFKFB3 expression and promoting the pentose phosphate pathway. Sci Rep 6:38067
Meng, Xuan; Tackmann, Nicole R; Liu, Shijie et al. (2016) RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression. Cancer Res 76:5030-9
Deisenroth, Chad; Franklin, Derek A; Zhang, Yanping (2016) The Evolution of the Ribosomal Protein-MDM2-p53 Pathway. Cold Spring Harb Perspect Med 6:

Showing the most recent 10 out of 55 publications